Delivery Order SPE2DB20D1102-SPE2DB23FC6AN
- Not listed
- This federal contract award is for the pharmaceutical product NEXTERONE 360 MG/200 ML BAG 200ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $2,431.10, is a delivery order with a firm fixed price. It has an ultimate completion date of January 27, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.96 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 28, 2026, for the supply of Nexterone 360 mg/200 ml bags. The order is a firm fixed-price contract with an ultimate completion date of January 29, 2026, and carries no set-aside designation, indicating it was competitively awarded. Performance will be conducted at the vendor's Conshohocken, Pennsylvania facility, where Amerisourcebergen maintains its...
- This federal contract award, valued at $1,354.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for HEXTEND 6%-LACT ELEC BAG 500ML medical supplies, with a completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award is a Delivery Order worth $1,495.58 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, and antibiotics. The contract...
- This federal contract award, valued at $1,018.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 29, 2025. This award is not associated with a set-aside program....
- This federal contract award, valued at $15,694.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the SPE2DX Indefinite Delivery Contract (IDC), a $999,999,999.00 global pharmaceutical support vehicle held by Amerisourcebergen. This award covers the delivery of a variety of pharmaceutical products and medical supplies, including medications across...
- This federal contract award is a Delivery Order valued at $143,826.00 between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a wide range of pharmaceutical products and medical supplies, including prescription medications, medical devices, specialty pharmaceuticals, vaccines, and other healthcare-related items. This Delivery Order is part of a larger Indefinite Delivery...
- This federal contract award, valued at $1,513.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of April 18, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support...
- This federal contract award, valued at $258,617.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides global pharmaceutical support to military healthcare programs. The contract does not have a set-aside designation,...
- This federal contract award, valued at $1,026.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB23FC6ANDelivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $1,021.58 for the supply of NEXTERONE 150 MG/100 ML BAG 100ML, a pharmaceutical product. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 22, 2023, with a completion date of February 23, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 2/22/23 |